LAWFUEL – The Law Newswire – The Bay Area is home to nearly half of the nation’s biotech industry by revenue, size or products. Industry thought leaders gather for BayBio 2007 to discuss the challenges and opportunities as they are met first by Bay Area companies – setting the course for the entire industry since more than thirty years.
What: BayBio 2007 is a one-day conference focusing on Northern California’s strength in life sciences innovators and innovations. Featured tracks will address the key topics for the industry: Money, People, Policy, Regulatory Affairs and Commercialization.
Who: Speakers from leading Northern California biotech companies, such as Alexza, Aerovance, Affymax, Aradigm, BioMarin, Bayer, ChemoCentryx, Dynavax, Exelixis, FivePrime, Genencor, Genentech, Genomic Health, Gilead, Intermune, Jazz, Nektar, OneWorld Health, XDx and others will share productive insights and practical skills in marketing, business development, operations, manufacturing, human resources, financing and corporate governance.
Thought leading speakers include:
Kimberly Belshé, State Secretary, California HHS
Dr. Pierre Cassigneul, President & CEO XDx Inc.
Dr. Andrew von Eschenbach, Commissioner, U.S. Food and Drug Administration
Dr. Gail Maderis, President & CEO FivePrime Therapeutics Inc.
Dr. Cynthia Robbins-Roth, BioVenture Consultants
When: Thursday, April 26, 8:30am – 5:30pm
Where: Crowne Plaza Hotel at San Francisco Airport
1177 Airport Blvd., Burlingame, CA 94010
FOR MORE INFORMATION, please visit. http://www.baybio.org/wt/home/BayBio2007
MEDIA REGISTRATION: Please contact Misha Tsirulnikov at (650) 871-7101 x205, [email protected] or visit: http://www.baybio.org/wt/home/media_registration
BayBio is Northern California’s life science association. We support the life science community through advocacy, enterprise support, best practice dissemination and enhancement of research collaboration. Our members include organizations engaged in or supportive of research, development, and commercialization of life science technologies.